Although α7nAChR is the oncogenic receptor responsible for most oncogenic responses in cancer, α9nAChR has recently become the focus of breast cancer research since α9nAChR is upregulated in estrogen receptor-positive breast cancer cells and stimulates the initiation and progression of breast cancer in coalition with the estrogen receptor [84]. This evidence concerns the gene CHRNA7 and breast carcinoma.